Epzicom

Product NDC
49349-701
11-digit product format
493490701
Labeler code
49349
Product ID
49349-701_d9d63875-a435-479f-ae39-e83ad7462d93
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Abacavir Sulfate and Lamivudine
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
NDA021652
Marketing category
NDA
Marketing start
2011-09-12
Marketing end
0000-00-00
Substance
ABACAVIR SULFATE; LAMIVUDINE
Active strength
600 mg/1; mg/1
Pharmacologic classes
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
49349-701-022019-11-13C16284748780-197449f38-b5d6-f6ea-e053-dbdaa90aa70385d4bdf1-3f4e-486f-a069-a6a7e21d3551
49349-701-192019-11-13C16284748780-197449f38-b5d6-f6ea-e053-dbdaa90aa70385d4bdf1-3f4e-486f-a069-a6a7e21d3551